U.S. overdose deaths involving psychostimulants other than cocaine, largely methamphetamine, increased 180% among adults under age 65 between 2015 and 2019, to 15,489, according to a study by the National Institute on Drug Abuse published this week in JAMA Psychiatry. The number of people reporting methamphetamine use increased 43% over the period, suggesting that increases in methamphetamine use disorder, frequent use and use of other drugs at the same time may be contributing to the rise in deaths, the authors said.

“What makes these data even more devastating is that currently, there are no approved medications to treat methamphetamine use disorder,” said Emily Einstein, chief of NIDA’s Science Policy Branch and a co-author of the study. 
 

Related News Articles

Headline
Nonprofit hospitals and health systems and other eligible entities can apply until April 14 for up to $2.5 million from the Agency for Healthcare Research and…
Headline
The Food and Drug Administration yesterday issued a report offering recommendations to address the opioid crisis and the role of analgesic oversight in…
Headline
Commenting today on a proposed rule to improve the exchange of patient records used in the treatment of substance use disorder, AHA said it supports the…
Headline
States, territories, health facilities and tribal organizations can apply through March 27 for up to $525,000 million each for residential treatment programs…
Headline
The share of U.S. overdose deaths involving buprenorphine did not increase after federal agencies allowed clinicians to prescribe the opioid use disorder…
Headline
Nonprofit hospitals and emergency departments, including free standing EDs and Rural Emergency Hospitals, can apply through March 6 for up to $500,000 per year…